CA2044570A1 - Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid - Google Patents
Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acidInfo
- Publication number
- CA2044570A1 CA2044570A1 CA 2044570 CA2044570A CA2044570A1 CA 2044570 A1 CA2044570 A1 CA 2044570A1 CA 2044570 CA2044570 CA 2044570 CA 2044570 A CA2044570 A CA 2044570A CA 2044570 A1 CA2044570 A1 CA 2044570A1
- Authority
- CA
- Canada
- Prior art keywords
- acid
- process according
- dimethylcyclopropanecarboxylic
- dimethylcyclopropanecarboxylic acid
- racemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- BFNMOMYTTGHNGJ-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1(C)CC1C(O)=O BFNMOMYTTGHNGJ-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 19
- 150000002148 esters Chemical class 0.000 claims abstract description 15
- 230000007062 hydrolysis Effects 0.000 claims abstract description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 12
- 238000002425 crystallisation Methods 0.000 claims abstract description 8
- 230000008025 crystallization Effects 0.000 claims abstract description 8
- 230000032050 esterification Effects 0.000 claims abstract description 8
- 238000005886 esterification reaction Methods 0.000 claims abstract description 8
- ITATYELQCJRCCK-UHFFFAOYSA-N Mandelic Acid, Methyl Ester Chemical compound COC(=O)C(O)C1=CC=CC=C1 ITATYELQCJRCCK-UHFFFAOYSA-N 0.000 claims abstract description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 13
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 10
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 8
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 7
- 239000002585 base Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 150000002440 hydroxy compounds Chemical class 0.000 claims description 3
- 239000012452 mother liquor Substances 0.000 claims description 3
- 230000020477 pH reduction Effects 0.000 claims description 2
- BRCRFYLVITWOAJ-UHFFFAOYSA-N (2-methoxy-2-oxo-1-phenylethyl) 2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=CC=CC=1C(C(=O)OC)OC(=O)C1CC1(C)C BRCRFYLVITWOAJ-UHFFFAOYSA-N 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 4
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 4
- 229960002510 mandelic acid Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- FMCGSUUBYTWNDP-ONGXEEELSA-N (1R,2S)-2-(dimethylamino)-1-phenyl-1-propanol Chemical compound CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 FMCGSUUBYTWNDP-ONGXEEELSA-N 0.000 description 2
- BFNMOMYTTGHNGJ-SCSAIBSYSA-N (1s)-2,2-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1(C)C[C@@H]1C(O)=O BFNMOMYTTGHNGJ-SCSAIBSYSA-N 0.000 description 2
- DTGGNTMERRTPLR-UHFFFAOYSA-N 1,2-diphenylethanamine Chemical class C=1C=CC=CC=1C(N)CC1=CC=CC=C1 DTGGNTMERRTPLR-UHFFFAOYSA-N 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 2
- FMCGSUUBYTWNDP-UHFFFAOYSA-N N-Methylephedrine Natural products CN(C)C(C)C(O)C1=CC=CC=C1 FMCGSUUBYTWNDP-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- ITATYELQCJRCCK-QMMMGPOBSA-N methyl (2s)-2-hydroxy-2-phenylacetate Chemical compound COC(=O)[C@@H](O)C1=CC=CC=C1 ITATYELQCJRCCK-QMMMGPOBSA-N 0.000 description 2
- 229940073569 n-methylephedrine Drugs 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229960000948 quinine Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940075966 (+)- menthol Drugs 0.000 description 1
- NOOLISFMXDJSKH-AEJSXWLSSA-N (+)-menthol Chemical compound CC(C)[C@H]1CC[C@H](C)C[C@@H]1O NOOLISFMXDJSKH-AEJSXWLSSA-N 0.000 description 1
- RQEUFEKYXDPUSK-ZETCQYMHSA-N (1S)-1-phenylethanamine Chemical compound C[C@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-ZETCQYMHSA-N 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- DHSUYTOATWAVLW-WFVMDLQDSA-N cilastatin Chemical compound CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O DHSUYTOATWAVLW-WFVMDLQDSA-N 0.000 description 1
- 229960004912 cilastatin Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- -1 for example Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960004873 levomenthol Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
A process is disclosed for preparing optically pure 2,2-dimethylcyclopropanecarboxylic acid, in which the enantiomers are separated from the racemate by esterification with the hydroxy group of optically active mandelic acid methyl ester, crystallization of the diastereomeric esters and subsequent hydrolysis of the diastereomeric esters.
A process is disclosed for preparing optically pure 2,2-dimethylcyclopropanecarboxylic acid, in which the enantiomers are separated from the racemate by esterification with the hydroxy group of optically active mandelic acid methyl ester, crystallization of the diastereomeric esters and subsequent hydrolysis of the diastereomeric esters.
Description
20~7~
This invention relates to the production of optically-pure 2,2-dimethylcyclopropanecarboxylic acid by resolution of its racemates.
This invention relates to the production of optically-pure 2,2-dimethylcyclopropanecarboxylic acid by resolution of its racemates.
2,2-Dimethylcyclopropanecarboxylic acid is an important intermediate product for the synthesis of the enzyme inhibitor cilastatin (European Patent No. 0,048,301) and of insecticides of the pyrethrin type ~British Patent No. 1,260,847).
In particular for the production of pharmaceutically active ingredients, it is desirable to have available 2,2-dimethylcyclopropanecarboxylic acid in optically pure form, i.e., in the form of the pure (S)-(+)- or pure (R)-t-~-enantiomer. Since the chemical synthesis of 2,2-dimethylcyclopropanecarboxylic acid provides the compound in the form of its racemate, it is necessary to perform a resolution of this racemate. Such resolutions of racemates are usually brought about by first converting the enantiomer mixture to be separated first into a mixture of diastereomeric derivatives by means of an optically active auxiliary substance, which can be separated because of the different physical properties of the diastereomers by fractionating crystalli2ation or chromatography. From the diastereomers thus separated, a pure enantiomer of the compound to be separated and the optically active auxiliary substance is then ideally set free in each case.
In reality, with a given auxiliary substance, even though suah substance is optically completely pure, in most cases only an incomplete separation of one pure enantiomer is possible, so that a mixture remains which mainly consists of the other enantiomer. In less advantageous cases, neither of the two enantiomers can be isolated in pure form. As derivatives of carboxylic acids for the purpose of the resolution of racemates, their salts with optically active bases, in particular amines, are often used. These salts have the advantage that they are .
20~4~
formed very easily and quickly and can also be cleaved again by adding a strong acid. For resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid, (S)-(-)-l-phenylethylamine (British Patent No. 1,260,847), (-)-N-methylephredrin (Japanese Published Patent Application Nos.
60-56936 and 60-56942), quinine (European Published Patent Application No. 0,161,546) and various 1,2-diphenylethylamines (European Published Patent Application No. 0,039,511) have already been used.
However, when using l-phenylethylamine, neither a satisfactory yield nor a sufficient optical purity was achievable. Quinine yielded an enantiomer with good optical purity, but in poor yield, no yield was indicated for N-methylephedrine. In the case of 1,2-diphenylethylamine, the yield is satisfactory and the optical purity is very good, but the reagent is very expensive, as also is N-methylephedrine.
Further, it is known that 2,2-dimethylcyclopropanecarboxylic acid can be separated into the enantiomers via the diastereomeric menthyl esters, which are obtainable from the acid chloride with (+)- or (-)-menthol (U.S. Patent No. 4,487,956). This process does provide usable yields and optical purities, but is relatively complicated in the working-up and requires the use of the relatively expensive menthol.
The main object of the invention is to provide a process for the resolution of the racemate of 2,2-dimethylcyclopropanecarboxylic acid, which is simple to perform and requires only reasonably priced optically-active auxiliary substances which are as nontoxic aspossible.
According to the invention, there is provided a process which involves resolution of the racemate of 2,2-dimethylcyclopropanecarboxylic acid by esterification with an optically active hydroxy compound, followed by fractionating crystallization of the formed diastereomeric .
.:
', 204~570 esters and subsequent hydrolysis of the crystallized diastereomeric esters. Mandelic acid methyl ester is used as the optically active hydroxy compound.
The fractionating crystallization of the 5 diastereomeric esters is preferably performed with an alkane as a solvent. Preferably n-hexane is used as the alkane. Preferably the esterification of 2,2-dimethylcyclopropanecarboxylic acid by the corresponding racemic acid chloride takes place in the presence of an 10 auxiliary base. The racemic acid chloride is preferably produced by the reaction of 2, 2-dimethylcyclopropanecarboxylic acid with thionyl chloride, Also preferably, the racemic acid chloride is produced by using the enantiomer mixture (recovered by hydrolysis from 15 the mother liquor of the crystallization) of 2,2-dimethylcyclopropanecarboxylic acid and is racemized by heating to 100 to 200 C. The hydrolysis of the esters of 2,2-dimethylcyclopropanecarboxylic acid is preferably performed with an aqueous alkali hydroxide. Preferably the 20 2,2-dimethylcyclopropanecarboxylic acid is isolated by acidification and extraction with n-hexane from the hydrolysis mixture.
Another aspect of the invention comprises alpha-(2,2-dimethylcyclopropanecarbonyloxy)-phenylacetic 25 acid methyl ester.
Thus, it has been found surprisingly that optically active mandelic acid methyl ester reacts not only with (RSj-2,2-dimethylcyclopropanecarboxylic acid chloride at the OH group smoothly to form the corresponding 30 diastereomeric esters, but that surprisingly the latter are also separable by fractioning crystallization and, after their hydrolysis, the released 2, 2-dimethylcyclopropanecarboxylic acid can be separated very easily from the likewise resultant mandelic acid. Nandelic 35 acid, in contrast to 2,2-dimethylcyclopropanecarboxylic acid, is practically insoluble in alkanes and remains in `
2 ~ 7 0 the aqueous phase during the extraction with these alkane solvents.
The process according to the invention is advantageously performed in such a way that the racemic 2,2-dimethylcyclopropanecarboxylic acid is first converted to the corresponding acid chloride. This step is known in the art and can be performed, for example, with thionyl chloride in the presence of a catalytic amount of N,N-dimethylformamide. The acid chloride thus obtained is purified advantageously by distillation. Then, the racemic acid chloride is reacted with optically active mandelic acid methyl ester while adding an auxiliary base to bond the resulting hydrochloric acid. As the auxiliary base, for example, pyridine may be used. The esterification is advantageously performed in an inert solvent, such as dichloromethane.
Of course, it is also within the scope of the invention to perform the esterification by the direct reaction of 2,2-dimethylcyclopropanecarboxylic acid with mandelic acid methyl ester in the presence of a catalyst, such as dicyclohexylcarbodiimide or 1,1'-carbonyldiimidazole. Such esterification methods are known to those skilled in the art and are described, for example, in "Methoden der organischen Chemie", [Methods of Organic Chemistry], (Houben-Weyl), 4th Edition, Vol. E5, p. 659 ff, and Vol. VIII, p. 516 ff.
The diastereomeric esters present after the esterification are fractionatingly crystallized: an alkane being preferably used as the solvent. n-Hexane is especially preferred as the solvent. The diastereomer with the same absolute configuration on both asymmetric centers crystallizes first from n-hexane.
T o o b t a i n ( S ) - ( + ) - 2 , 2 -dimethylcyclopropanecarboxylic acid in optically pure form, (S)-(+)-mandelic acid methyl ester is therefore used advantageously, the (R)-ester being correspondingly used :
2 ~ 7 ~
for the (R)-acid. An advantage of the process according to the invention lies in the fact that both enantiomers of mandelic acid and, thus, also their esters are easily accessible.
After the isolation of the desired diastereomeric ester, the latter is hydrolyzed. The hydrolysis is preferably performed according to a conventional method with aqueous alkali hydroxide solution, and both ester groups are hydrolyzed in the molecule. Then, by adding a strong acid, for example hydrochloric acid, 2,2-dimethylcyclopropanecarboxylic acid and mandelic acid (which are present as anions after the hydrolysis) are released. The separation of the optically-pure 2,2-dimethylcyclopropanecarboxylic acid takes place preferably by extraction with a nonpolar solvent. Especially preferred as extracting agents are the straight-chain, branched or cyclic alkanes having 5 to 10 C atoms. Most especially preferred is n-hexane, in which mandelic acid is practically insoluble.
T h e o p t i c a l l y - p u r e 2 , 2 -dimethylcyclopropanecarboxylic acid thus obtained can be further processed in known manner, for example by conversion to the acid chloride and further to the amide.
In order to make use of the mother liquor of the crystallization (in which the more easily soluble diastereomer is concentrated) the latter is advantageously also subjected to a hydrolysis.
The enantiomer mixture thus obtained is suitably converted again to the mixture of the acid chlorides, which can be racemized in a manner known in the art by heating to 100 to 200 C. The thus obtainable racemic acid chloride can again be added to the initial material of the process according to the invention, so that neither the undesirable enantiomer has to be removed nor do significant losses ~5 occur.
: ,:
' ,; , :
.
2 ~ 7 0 The following examples illustrate the performance of the process according to the invention.
Example 1 (RS)-2 2-dimethylcyclopropanecarboxylic acid chloride 52.8 g of (RS)-2,2-dimethylcyclopropanecarboxylic acid and 0.25 g of N,N-dimethylformamide were dissolved in 50 ml of n-hexane and mixed under reflux by instillation with 104.0 g of thionyl chloride in 100 ml of n-hexane.
After a further 2 hours of stirring under reflux, the solvent was distilled off and the residue was quickly distilled at 200 mbars and 100 C (bath temperature). The yield of the product was 55.0 g.
Example 2 (S.S)-alpha-(2.2-dimethylcyclopropanecarbonyloxy)phenyl-acetic acid methyl ester 14.0 g of (S)-2,2-dimethyIcyclopropanecarboxylic acid chloride was dissolved in 70 ml of dichloromethane, cooled to 0 C and mixed as quickly as possible with 8.1 g of pyridine. Then a solution of 17.0 g of (S)-(+)-mandelic acid methyl ester {[a]D2=+146.5 (c = 1, MeOH)3 in 35 ml of dichloromethane was instilled in this mixture at 0 to 5 C
over 10 minutes. The reaction mixture was stirred for a further 2 ho~rs at room temperature and then washed successively with water, dilute hydrochloric acid and again with water. The organic phase was dried on sodium sulfate and concentrated by evaporation. The crude product thus obtained (26.0 g) was suspended in 7.0 ml of n-hexane at room temperature. The crystalline residue was filtered off, dried and recrystallized three times hot from 40 ml of n-hexane, each time. The yield of (S,S)-alpha-2,2-dimethylcyclopropanecarbonyloxy)phenylacetic acid methyl ester was 7.6 g. Other data for the product were:
Melting point: 80 to 82 C, colorless crystals ~a]D20: +158.0 (c = 1, CHCl3) 1H-NMR (300 MHz, C6D6):
.
.
.
2 ~ 7 0 ~7.43 to 7.52 (m, 2H), 6.97 to 7.12 (m, 3H), 6.11 (s, lH), 3.19 (s, 3H), 1.55 to 1.60 (m, lH), 1.39 (s, 3H), 1.19 to 1.23 (m, lH), 0.86 (s, 3H), 0.55 to 0.60 (m, lH) Example 3 (S~-(+)-2~2-Dimethylcyclopropanecarboxylic acid 1 8 . 4 g o f ( S , S ) - a 1 p h a - ( 2 , 2 -dimethylcyclopropanecarbonyloxy)phenylacetic acid methyl ester (produced according to Example 2) was mixed with a solution of 20.6 g of potassium hydroxide (85 percent) in 235 ml of water and stirred for 6 hours at 80C, and a clear solution was formed. Then the reaction mixture was cooled to room temperature and acidified to pH 1 with dilute hydrochloric acid. The aqueous solution was extracted four times with 100 ml of n-hexane, each time.
The combined organic phases were dried on sodium sulfate and filtered. After distilling off the solvent, (S)-(+)-2,2-dimethylcyclopropanecarboxylic acid was obtained in a purity (GC) of 99.0 percent. The yield of the product was 7.7 g. Other data for the product were: [~] D20: +14 6 (neat), corresponding to an optical purity (ee value) greater than or equal to 98 percent.
Example 4 2S Racemization of 2.2-dimethylcyclopropan _arboxylic acid From the mother liquors resulting during the c ry 5 t a 1 1 iz at i on o f (S, S) -a 1 p h a - (2 , 2 -dimethylcyclopropanecarbonyloxy)phenylacetic acid methyl ester according to Example 2, the solvent was distilled off and the residue, analogously to Example 3, was hydrolyzed alkaline and worked up. 11.4 g of 2,2-dimethylcyclopropanecarboxylic acid (~D20 = -51.8 (c = 1, CHCl3)), consisting of 69 percent of the (R)-(-)- form and 31 percent of the (S)-(+)- form, was obtained. The enantiomer mixture was diluted with 12.0 g of hexane, heated to 75 C and was mixed over 30 minutes by . : ,-. , , -. , , . :
., . ..: .
.
- . .
.. . ~
--2 ~ 7 ~ -instillation with a mixture of 17.9 g of thionyl chloride and 5.0 g of hexane and refluxed for a further 2.5 hours.
The solvent and the excess thionyl chloride were distilled off and the residue was heated to 135 C with stirring for 2 hours. After cooling to room temperature, the acid chloride mixture was hydrolyzed with dilute sodium hydroxide solution, and the resultant aqueous solution was extracted twice with 10 g of toluene, each time. The organic phase was discarded; and the aqueous phase was acidified with concentrated hydrochloric acid and extracted five times with 40 g of hexane, each time. 11.4 g of crude 2,2-dimethylcyclopropanecarboxylic acid, which was distilled in the water jet vacuum, was obtained from the hexane phases by distilling off the solvent. The yield was 9.4 g (83 percent) of colorless, fetid liquid consisting of 48.5 percent of the (S)-(+)- form and 51.5 percent of the (R)-(-)- form.
, .
In particular for the production of pharmaceutically active ingredients, it is desirable to have available 2,2-dimethylcyclopropanecarboxylic acid in optically pure form, i.e., in the form of the pure (S)-(+)- or pure (R)-t-~-enantiomer. Since the chemical synthesis of 2,2-dimethylcyclopropanecarboxylic acid provides the compound in the form of its racemate, it is necessary to perform a resolution of this racemate. Such resolutions of racemates are usually brought about by first converting the enantiomer mixture to be separated first into a mixture of diastereomeric derivatives by means of an optically active auxiliary substance, which can be separated because of the different physical properties of the diastereomers by fractionating crystalli2ation or chromatography. From the diastereomers thus separated, a pure enantiomer of the compound to be separated and the optically active auxiliary substance is then ideally set free in each case.
In reality, with a given auxiliary substance, even though suah substance is optically completely pure, in most cases only an incomplete separation of one pure enantiomer is possible, so that a mixture remains which mainly consists of the other enantiomer. In less advantageous cases, neither of the two enantiomers can be isolated in pure form. As derivatives of carboxylic acids for the purpose of the resolution of racemates, their salts with optically active bases, in particular amines, are often used. These salts have the advantage that they are .
20~4~
formed very easily and quickly and can also be cleaved again by adding a strong acid. For resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid, (S)-(-)-l-phenylethylamine (British Patent No. 1,260,847), (-)-N-methylephredrin (Japanese Published Patent Application Nos.
60-56936 and 60-56942), quinine (European Published Patent Application No. 0,161,546) and various 1,2-diphenylethylamines (European Published Patent Application No. 0,039,511) have already been used.
However, when using l-phenylethylamine, neither a satisfactory yield nor a sufficient optical purity was achievable. Quinine yielded an enantiomer with good optical purity, but in poor yield, no yield was indicated for N-methylephedrine. In the case of 1,2-diphenylethylamine, the yield is satisfactory and the optical purity is very good, but the reagent is very expensive, as also is N-methylephedrine.
Further, it is known that 2,2-dimethylcyclopropanecarboxylic acid can be separated into the enantiomers via the diastereomeric menthyl esters, which are obtainable from the acid chloride with (+)- or (-)-menthol (U.S. Patent No. 4,487,956). This process does provide usable yields and optical purities, but is relatively complicated in the working-up and requires the use of the relatively expensive menthol.
The main object of the invention is to provide a process for the resolution of the racemate of 2,2-dimethylcyclopropanecarboxylic acid, which is simple to perform and requires only reasonably priced optically-active auxiliary substances which are as nontoxic aspossible.
According to the invention, there is provided a process which involves resolution of the racemate of 2,2-dimethylcyclopropanecarboxylic acid by esterification with an optically active hydroxy compound, followed by fractionating crystallization of the formed diastereomeric .
.:
', 204~570 esters and subsequent hydrolysis of the crystallized diastereomeric esters. Mandelic acid methyl ester is used as the optically active hydroxy compound.
The fractionating crystallization of the 5 diastereomeric esters is preferably performed with an alkane as a solvent. Preferably n-hexane is used as the alkane. Preferably the esterification of 2,2-dimethylcyclopropanecarboxylic acid by the corresponding racemic acid chloride takes place in the presence of an 10 auxiliary base. The racemic acid chloride is preferably produced by the reaction of 2, 2-dimethylcyclopropanecarboxylic acid with thionyl chloride, Also preferably, the racemic acid chloride is produced by using the enantiomer mixture (recovered by hydrolysis from 15 the mother liquor of the crystallization) of 2,2-dimethylcyclopropanecarboxylic acid and is racemized by heating to 100 to 200 C. The hydrolysis of the esters of 2,2-dimethylcyclopropanecarboxylic acid is preferably performed with an aqueous alkali hydroxide. Preferably the 20 2,2-dimethylcyclopropanecarboxylic acid is isolated by acidification and extraction with n-hexane from the hydrolysis mixture.
Another aspect of the invention comprises alpha-(2,2-dimethylcyclopropanecarbonyloxy)-phenylacetic 25 acid methyl ester.
Thus, it has been found surprisingly that optically active mandelic acid methyl ester reacts not only with (RSj-2,2-dimethylcyclopropanecarboxylic acid chloride at the OH group smoothly to form the corresponding 30 diastereomeric esters, but that surprisingly the latter are also separable by fractioning crystallization and, after their hydrolysis, the released 2, 2-dimethylcyclopropanecarboxylic acid can be separated very easily from the likewise resultant mandelic acid. Nandelic 35 acid, in contrast to 2,2-dimethylcyclopropanecarboxylic acid, is practically insoluble in alkanes and remains in `
2 ~ 7 0 the aqueous phase during the extraction with these alkane solvents.
The process according to the invention is advantageously performed in such a way that the racemic 2,2-dimethylcyclopropanecarboxylic acid is first converted to the corresponding acid chloride. This step is known in the art and can be performed, for example, with thionyl chloride in the presence of a catalytic amount of N,N-dimethylformamide. The acid chloride thus obtained is purified advantageously by distillation. Then, the racemic acid chloride is reacted with optically active mandelic acid methyl ester while adding an auxiliary base to bond the resulting hydrochloric acid. As the auxiliary base, for example, pyridine may be used. The esterification is advantageously performed in an inert solvent, such as dichloromethane.
Of course, it is also within the scope of the invention to perform the esterification by the direct reaction of 2,2-dimethylcyclopropanecarboxylic acid with mandelic acid methyl ester in the presence of a catalyst, such as dicyclohexylcarbodiimide or 1,1'-carbonyldiimidazole. Such esterification methods are known to those skilled in the art and are described, for example, in "Methoden der organischen Chemie", [Methods of Organic Chemistry], (Houben-Weyl), 4th Edition, Vol. E5, p. 659 ff, and Vol. VIII, p. 516 ff.
The diastereomeric esters present after the esterification are fractionatingly crystallized: an alkane being preferably used as the solvent. n-Hexane is especially preferred as the solvent. The diastereomer with the same absolute configuration on both asymmetric centers crystallizes first from n-hexane.
T o o b t a i n ( S ) - ( + ) - 2 , 2 -dimethylcyclopropanecarboxylic acid in optically pure form, (S)-(+)-mandelic acid methyl ester is therefore used advantageously, the (R)-ester being correspondingly used :
2 ~ 7 ~
for the (R)-acid. An advantage of the process according to the invention lies in the fact that both enantiomers of mandelic acid and, thus, also their esters are easily accessible.
After the isolation of the desired diastereomeric ester, the latter is hydrolyzed. The hydrolysis is preferably performed according to a conventional method with aqueous alkali hydroxide solution, and both ester groups are hydrolyzed in the molecule. Then, by adding a strong acid, for example hydrochloric acid, 2,2-dimethylcyclopropanecarboxylic acid and mandelic acid (which are present as anions after the hydrolysis) are released. The separation of the optically-pure 2,2-dimethylcyclopropanecarboxylic acid takes place preferably by extraction with a nonpolar solvent. Especially preferred as extracting agents are the straight-chain, branched or cyclic alkanes having 5 to 10 C atoms. Most especially preferred is n-hexane, in which mandelic acid is practically insoluble.
T h e o p t i c a l l y - p u r e 2 , 2 -dimethylcyclopropanecarboxylic acid thus obtained can be further processed in known manner, for example by conversion to the acid chloride and further to the amide.
In order to make use of the mother liquor of the crystallization (in which the more easily soluble diastereomer is concentrated) the latter is advantageously also subjected to a hydrolysis.
The enantiomer mixture thus obtained is suitably converted again to the mixture of the acid chlorides, which can be racemized in a manner known in the art by heating to 100 to 200 C. The thus obtainable racemic acid chloride can again be added to the initial material of the process according to the invention, so that neither the undesirable enantiomer has to be removed nor do significant losses ~5 occur.
: ,:
' ,; , :
.
2 ~ 7 0 The following examples illustrate the performance of the process according to the invention.
Example 1 (RS)-2 2-dimethylcyclopropanecarboxylic acid chloride 52.8 g of (RS)-2,2-dimethylcyclopropanecarboxylic acid and 0.25 g of N,N-dimethylformamide were dissolved in 50 ml of n-hexane and mixed under reflux by instillation with 104.0 g of thionyl chloride in 100 ml of n-hexane.
After a further 2 hours of stirring under reflux, the solvent was distilled off and the residue was quickly distilled at 200 mbars and 100 C (bath temperature). The yield of the product was 55.0 g.
Example 2 (S.S)-alpha-(2.2-dimethylcyclopropanecarbonyloxy)phenyl-acetic acid methyl ester 14.0 g of (S)-2,2-dimethyIcyclopropanecarboxylic acid chloride was dissolved in 70 ml of dichloromethane, cooled to 0 C and mixed as quickly as possible with 8.1 g of pyridine. Then a solution of 17.0 g of (S)-(+)-mandelic acid methyl ester {[a]D2=+146.5 (c = 1, MeOH)3 in 35 ml of dichloromethane was instilled in this mixture at 0 to 5 C
over 10 minutes. The reaction mixture was stirred for a further 2 ho~rs at room temperature and then washed successively with water, dilute hydrochloric acid and again with water. The organic phase was dried on sodium sulfate and concentrated by evaporation. The crude product thus obtained (26.0 g) was suspended in 7.0 ml of n-hexane at room temperature. The crystalline residue was filtered off, dried and recrystallized three times hot from 40 ml of n-hexane, each time. The yield of (S,S)-alpha-2,2-dimethylcyclopropanecarbonyloxy)phenylacetic acid methyl ester was 7.6 g. Other data for the product were:
Melting point: 80 to 82 C, colorless crystals ~a]D20: +158.0 (c = 1, CHCl3) 1H-NMR (300 MHz, C6D6):
.
.
.
2 ~ 7 0 ~7.43 to 7.52 (m, 2H), 6.97 to 7.12 (m, 3H), 6.11 (s, lH), 3.19 (s, 3H), 1.55 to 1.60 (m, lH), 1.39 (s, 3H), 1.19 to 1.23 (m, lH), 0.86 (s, 3H), 0.55 to 0.60 (m, lH) Example 3 (S~-(+)-2~2-Dimethylcyclopropanecarboxylic acid 1 8 . 4 g o f ( S , S ) - a 1 p h a - ( 2 , 2 -dimethylcyclopropanecarbonyloxy)phenylacetic acid methyl ester (produced according to Example 2) was mixed with a solution of 20.6 g of potassium hydroxide (85 percent) in 235 ml of water and stirred for 6 hours at 80C, and a clear solution was formed. Then the reaction mixture was cooled to room temperature and acidified to pH 1 with dilute hydrochloric acid. The aqueous solution was extracted four times with 100 ml of n-hexane, each time.
The combined organic phases were dried on sodium sulfate and filtered. After distilling off the solvent, (S)-(+)-2,2-dimethylcyclopropanecarboxylic acid was obtained in a purity (GC) of 99.0 percent. The yield of the product was 7.7 g. Other data for the product were: [~] D20: +14 6 (neat), corresponding to an optical purity (ee value) greater than or equal to 98 percent.
Example 4 2S Racemization of 2.2-dimethylcyclopropan _arboxylic acid From the mother liquors resulting during the c ry 5 t a 1 1 iz at i on o f (S, S) -a 1 p h a - (2 , 2 -dimethylcyclopropanecarbonyloxy)phenylacetic acid methyl ester according to Example 2, the solvent was distilled off and the residue, analogously to Example 3, was hydrolyzed alkaline and worked up. 11.4 g of 2,2-dimethylcyclopropanecarboxylic acid (~D20 = -51.8 (c = 1, CHCl3)), consisting of 69 percent of the (R)-(-)- form and 31 percent of the (S)-(+)- form, was obtained. The enantiomer mixture was diluted with 12.0 g of hexane, heated to 75 C and was mixed over 30 minutes by . : ,-. , , -. , , . :
., . ..: .
.
- . .
.. . ~
--2 ~ 7 ~ -instillation with a mixture of 17.9 g of thionyl chloride and 5.0 g of hexane and refluxed for a further 2.5 hours.
The solvent and the excess thionyl chloride were distilled off and the residue was heated to 135 C with stirring for 2 hours. After cooling to room temperature, the acid chloride mixture was hydrolyzed with dilute sodium hydroxide solution, and the resultant aqueous solution was extracted twice with 10 g of toluene, each time. The organic phase was discarded; and the aqueous phase was acidified with concentrated hydrochloric acid and extracted five times with 40 g of hexane, each time. 11.4 g of crude 2,2-dimethylcyclopropanecarboxylic acid, which was distilled in the water jet vacuum, was obtained from the hexane phases by distilling off the solvent. The yield was 9.4 g (83 percent) of colorless, fetid liquid consisting of 48.5 percent of the (S)-(+)- form and 51.5 percent of the (R)-(-)- form.
, .
Claims (9)
1. Process for resolution of racemic 2,2-dimethylcyclopropanecarboxylic acid comprising esterifying the racemate of 2,2-dimethylcyclopropanecarboxylic acid with an optically active hydroxy compound, which is mandelic acid methyl ester, fractionating crystallizing the formed diastereomeric esters and subsequently hydrolyzing the crystallized diastereomeric esters.
2. A process according to claim 1, wherein the fractionating crystallization of the diastereomeric esters is performed with an alkane as a solvent.
3. A process according to claim 2, wherein the alkane is n-hexane.
4. A process according to claim 1, wherein the esterification of 2,2-dimethylcyclopropanecarboxylic acid by the corresponding racemic acid chloride takes place int he presence of an auxiliary base.
5. A process according to claim 4, wherein the racemic acid chloride is produced by the reaction of 2,2-dimethylcyclopropanecarboxylic acid with thionyl chloride.
6. A process according to claim 4 or 5, wherein the racemic acid chloride is produced by using the enantiomer mixture of 2,2-dimethylcyclopropanecarboxylic acid recovered by hydrolysis from the mother liquor of the crystallization step, and is racemized by heating to 100 to 200 C.
7. A process according to claim 1, 2, 3, 4 or 5, wherein the hydrolysis of the esters of 2,2-dimethylcyclopropanecarboxylic acid is performed with an aqueous alkali hydroxide.
8. A process according to claim 1, 2, 3, 4, or 5, wherein 2,2-dimethylcyclopropanecarboxylic acid is isolated by acidification and extraction with n-hexane from the hydrolysis mixture.
9. Alpha-(2,2-dimethylcyclopropanecarbonyloxy)-phenylacetic acid methyl ester.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2044570 CA2044570A1 (en) | 1990-06-14 | 1991-06-13 | Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1999/90 | 1990-06-14 | ||
| CA 2044570 CA2044570A1 (en) | 1990-06-14 | 1991-06-13 | Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2044570A1 true CA2044570A1 (en) | 1991-12-15 |
Family
ID=4147813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2044570 Abandoned CA2044570A1 (en) | 1990-06-14 | 1991-06-13 | Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2044570A1 (en) |
-
1991
- 1991-06-13 CA CA 2044570 patent/CA2044570A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0462776B1 (en) | Preparation of optically active arylaliphatic carboxylic acids | |
| US5281722A (en) | Preparation and use of salts of the pure enantiomers of alpha-lipoic acid | |
| CA2150355C (en) | Process of resolving phenylpropionic acids using alpha-methylbenzylamine | |
| US5243070A (en) | Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid | |
| US4546201A (en) | Process for the optical resolution of (±)2-(6'methoxy-2'-naphthyl)-propionic acid | |
| US5235095A (en) | Preparation of optically active aliphatic carboxylic acids | |
| CN101743218B (en) | Preparation method and intermediate of optically active trans-2-aminocyclohexanol | |
| US4345090A (en) | Process for preparing menthyl esters of enantiomers of chiral 3-(2,2-dichloro- and -dibromo-vinyl)-2,2-dimethylcyclopropanecarboxylic acids | |
| CA2044570A1 (en) | Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid | |
| JP5598330B2 (en) | Process for producing optically active organic carboxylic acid | |
| EP0093511B1 (en) | Method for producing and optically active 2,2-dimethylcyclopropanecarboxylic acid | |
| JPH04308550A (en) | Method of stereoselectively converting diol into alcohol | |
| US4111980A (en) | Process for preparing optically active phenyl glycine | |
| CA2128519A1 (en) | Preparation of optically active aliphatic carboxylic acids | |
| US5254756A (en) | Process for the production of (2R,3E)-4-halo-3-buten-2-ols | |
| US5166417A (en) | Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid | |
| US5900492A (en) | Method of producing optically active cyclopropane derivatives | |
| US5977391A (en) | (+)- and (-) -8-halogen-6- hydroxy-octanoic acid its salts and esters and process for making | |
| US4508919A (en) | Process for the preparation of optically active cyclopropane carboxylic acids | |
| US5869713A (en) | (+)- or (-) -8-halogen-6-hydroxy-octanoic acid, its salts and esters, and process for making | |
| JP2008536810A (en) | Process for producing enantiopure E- (2S) -alkyl-5-halopent-4-enoic acid and ester | |
| KR102055702B1 (en) | Method for the preparation of optically active 2-Octylglycine ester | |
| JPH03261743A (en) | Optical resolution of jasmonic acid and dihydrojasmonic acid | |
| JP2877976B2 (en) | Optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and method for producing the same | |
| JP3829266B2 (en) | Optically active amino acid ester, method for producing the same, and method for producing optically active 2-methoxycyclohexanol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |